文献速递临床试验与 GCP医学人工智能与信息学

基于智能手机的产后抑郁症状干预(Smart-e-Moms):一项随机对照试验的研究方案

Smartphone-based intervention for postpartum depressive symptoms (Smart-e-Moms): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-07-10

本研究为在德国开展的两臂随机对照试验,计划按1:1随机分配556名参与者,评估基于智能手机的干预“Smart-e-Moms”相比常规治疗对照组的有效性。干预组使用包含10个简短模块、基于认知行为疗法的预防性智能手机干预,主要结局为爱丁堡产后抑郁量表测量的产后抑郁症状,并分析母婴联结、压力水平、自我效能、干预满意度及医疗服务利用等次要结局。

要点

  • 计划随机分配556名参与者,干预组与常规治疗对照组按1:1比例分组。
  • 干预组使用包含10个简短模块、基于认知行为疗法的预防性智能手机干预“Smart-e-Moms”。
  • 主要结局为爱丁堡产后抑郁量表测量的产后抑郁症状,随访至基线后24周。

核心结论

  • 若Smart-e-Moms被证明有效,它可能在德语区的产后抑郁照护中发挥重要作用。
  • 该干预理想情况下不仅有益于母亲健康,也可能改善儿童健康发展的前景。

研究设计与样本

  • 在德国开展的两臂随机对照试验,比较基于智能手机的干预与常规治疗对照组。
  • 计划按1:1比例随机分配556名参与者。
  • 干预组在基线(t0)、第4次和第8次会话前(中间评估)以及基线后6周完成干预时(t1)接受评估。
  • 对照组在基线(t0)和基线后6周接受评估。
  • 随访评估安排在基线后12周和24周,以考察所观察效应的短期稳定性。

主要发现

  • 预期干预组参与者的产后抑郁症状(以爱丁堡产后抑郁量表测量)会改善。
  • 将分析次要结局,包括母婴联结、压力水平、自我效能、干预满意度和医疗服务利用。

关键数值与推荐

  • 主要结局为爱丁堡产后抑郁量表测量的产后抑郁症状。
  • 次要结局包括母婴联结、压力水平、自我效能、干预满意度和医疗服务利用。
  • 干预组使用名为“Smart-e-Moms”的预防性智能手机干预,包含10个基于认知行为疗法的简短模块,并提供治疗性支持。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postpartum depression constitutes a significant public health issue, with prevalence rates ranging between 8 and 19% in high-income nations. Nevertheless, numerous barriers, including time constraints, societal stigmatization, and feelings of shame, contribute to the limited utilization of healthcare services during the postpartum period. Digital interventions offer an opportunity to enhance care for women experiencing postpartum depressive symptoms. METHODS: We will conduct a two-arm randomized controlled trial to assess the effectiveness of a smartphone-based intervention in comparison to a treatment-as-usual control group in Germany. Our aim is to randomize 556 participants in a 1:1 ratio. Participants in the intervention group will be provided access to a preventive smartphone-based intervention called "Smart-e-Moms," which incorporates therapeutic support and comprises 10 concise modules rooted in cognitive-behavioral therapy. For the intervention group, evaluations will take place at baseline (t0), prior to sessions 4 and 8 (intermediate assessments), and upon completing the intervention 6 weeks after baseline (t1). The control group's assessments will be at baseline (t0) and 6 weeks after baseline. Follow-up assessments are scheduled at 12 and 24 weeks from baseline to examine the short-term stability of any observed effects. We anticipate that participants in the intervention group will exhibit improvements in their postpartum depressive symptoms (as measured with the Edinburgh Postnatal Depression Scale). Additionally, we will analyze secondary outcomes, including maternal bonding, stress levels, self-efficacy, satisfaction with the intervention, and healthcare utilization. DISCUSSION: If Smart-e-Moms proves to be effective, it has the potential to play a significant role in postpartum depression care within German-speaking regions. Ideally, this intervention could not only benefit maternal well-being but also improve the prospects for healthy child development. TRIAL REGISTRATION: German clinical trials registry DRKS00032324. Registered on January 26, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Daehn D, Meyer C, Loew V, et al. Smartphone-based intervention for postpartum depressive symptoms (Smart-e-Moms): study protocol for a randomized controlled trial. Trials. 2024. PMID: 38987846. doi:10.1186/s13063-024-08304-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。